Dr. Michelle P. Hudspeth

Dr. Michelle Hudspeth is a 1999 graduate of the MUSC College of Medicine and completed her residency, chief residency, and fellowship at the Johns Hopkins Hospital and the National Cancer Institute. She is the division chief for pediatric hematology/oncology and is the director of the pediatric blood and marrow transplant program and the quality director for the combined adult and pediatric blood and marrow transplant program. Her main clinical focus is transplantation, including haploidentical, related and unrelated allogeneic, cord blood, and autologous donor sources. She is the institutional principal investigator for Pediatric Blood and Marrow Transplant Consortium trials. She is a member of the Pediatric Blood and Marrow Transplant Consortium GVHD committee and supportive care committee. She also serves on several working committees (GVHD, pediatric cancer, immune deficiencies/inborn errors of metabolism) for the Center for International Blood and Marrow Transplant Research. Her clinical research includes multiple aspects of transplantation, including a clinical trial incorporating pravastatin for matched related donor transplants for sickle cell disease.

Dr. Hudspeth is highly rated in 2 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Infantile Neutropenia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Thymectomy.

Her clinical research consists of co-authoring 32 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.